Safety of multiple, simultaneous continuous peripheral nerve block catheters in a patient receiving therapeutic low-molecular-weight heparin

Pain Medicine

Volumn 9, Issue 5, 2008, Pages 624-627

  Plunkett, Anthony R ^a   Buckenmaier, Chester C ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Anticoagulation; Continuous Peripheral Nerve Block; Pain Management; Trauma

Indexed keywords

ANALGESIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; ROPIVACAINE;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BATTLE INJURY; CASE REPORT; CATHETER COMPLICATION; CATHETERIZATION; CONTINUOUS INFUSION; CONTINUOUS PERIPHERAL NERVE BLOCK; DRUG BLOOD LEVEL; DRUG INFUSION; EPIDURAL CATHETER; FEMORAL VEIN; HUMAN; INJURY; LOADING DRUG DOSE; MALE; MULTIPLE TRAUMA; NERVE BLOCK; REPEATED DRUG DOSE; SCIATIC NERVE; SOLDIER; TIBIA FRACTURE; ULNA FRACTURE;

ADULT; AMIDES; ANESTHETICS, LOCAL; ANTICOAGULANTS; CATHETERIZATION; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; NERVE BLOCK; PAIN; THROMBOSIS;

EID: 48449089021     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2008.00418.x     Document Type: Article

References (15)

1. Horlocker TT, Wedel DJ, Benzon H, et al. Regional anesthesia in the anticoagulated patient: Defining the risks (the second ASRA consensus conference on neuraxial anesthesia and anticoagulation). Reg Anesth Pain Med 2003;28(3):172-97.
2. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: The seventh ACCP conference on antithromboic and thrombolytic therapy. Chest 2004;126(suppl):338S-400S.
3. Stojadinovic A, Auton A, Peoples GE, et al. Responding to challenges in modern combat casualty care: Innovative use of advanced regional anesthesia. Pain Med 2006;7(4):330-8.
4. Tryba M. European practice guidelines: Thrombo-embolism prophylaxis and regional anesthesia. Reg Anesth Pain Med 1998;23:178-82.
5. Moen V, Dahlgren N, Irestedt L. Severe neurological complications after central neuraxial blockades in Sweden 1990-1999. Anesthesiology 2004;101:950-9.
6. Tryba M, Wedel DJ. Central neuraxial block and low molecular weight heparin (enoxaparin): Lessons learned from two different dosage regimens in two continents. Acta Anaesthesiol Scand 1997;41:100-4.
7. Buller HR, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease. Chest 2004;126(suppl):401S-28S.
8. Winnie AP, Ramamurthy S, Durrani Z, Radonjic R. Plexus blocks for lower extremity surgery. New answers to old problems. Anesthesiology 1974;1:11-6.
9. Klein SM, D'Ercole F, Greengrass RA, Warner DS. Enoxaparin associated with psoas hematoma and lumbar plexopathy after lumbar plexus block. Anesthesiology 1997;87(6):1576-9.
10. Weller RS, Gerancher JC, Crews JC, Wade KL. Extensive retroperitoneal hematoma without neurologic deficit in two patients who underwent lumbar plexus block and were later anticoagulated. Anesthesiology 2003;98(2):581-5.
11. Ruetsch YA, Fattinger KE, Borgeat A. Ropivacaine-induced convulsions and severe cardiac dysrhythmias after sciatic block. Anesthesiology 1999;90:1784-6.
12. Burm AGL, Stienstra R, Brouwer RP, Emanuelsson BM, van Kleef JW. Epidural infusion of ropivacaine for postoperative analgesia after major orthopedic surgery. Anesthesiology 2000;93:395-403.
13. Knudsen K, Beckman Suurküla M, Blomberg S, Sjovall N, Edvardsson N. Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. Br J Anaesth 1997;78:507-14.
14. Hansen TG, Ilett KF, Reid C, Hackett LP, Bergesio R. Pharmacokinetics and clinical efficacy of long term epidural ropivacaine infusion in children. Br J Anaesth 2000;85(3):347-53.
15. Buckenmaier CC, Shields CH, Auton AA. Continuous peripheral nerve block in combat casualties receiving low-molecular weight heparin. Br J Anaesth 2006;97:874-7.